Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Translational Development Acquisition (TDAC) Income from Continuing Operations (2024 - 2026)

Translational Development Acquisition's Income from Continuing Operations history spans 3 years, with the latest figure at 1332797.0 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations fell 10.13% to 1332797.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 6086804.0, a 331.06% increase, with the full-year FY2025 number at 6362427.0, up 9059.65% from a year prior.
  • Income from Continuing Operations came in at 1332797.0 for Q1 2026, down from 1470543.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 1660122.0 in Q3 2025, with the low at 61283.0 in Q3 2024.
  • Historically, Income from Continuing Operations has averaged 937358.25 across 3 years, with a median of 1401670.0 in 2025.
  • Biggest five-year swings in Income from Continuing Operations: skyrocketed 96440.77% in 2025 and later fell 10.13% in 2026.
  • Year by year, Income from Continuing Operations stood at 8044.0 in 2024, then soared by 18381.24% to 1470543.0 in 2025, then dropped by 9.37% to 1332797.0 in 2026.
  • Business Quant data shows Income from Continuing Operations for TDAC at 1332797.0 in Q1 2026, 1470543.0 in Q4 2025, and 1660122.0 in Q3 2025.